What is the life expectancy of someone with Sacrococcygeal Teratoma?

The life expectancy for individuals with Sacrococcygeal Teratoma (SCT) is generally excellent when the tumor is diagnosed early and treated with surgical resection, though outcomes depend heavily on the tumor's size, complexity, and potential for malignancy. While historically challenging, advancements in fetal intervention and neonatal surgery have significantly improved survival rates, allowing most children to lead full and active lives.

What factors influence the prognosis of Sacrococcygeal Teratoma?

The prognosis for Sacrococcygeal Teratoma is primarily determined by the timing of diagnosis and the presence of fetal complications. Prenatal ultrasound detection allows for specialized care teams to manage potential issues like high-output heart failure or hydrops fetalis. Factors that influence long-term health include:

• Tumor Histology: Whether the Sacrococcygeal Teratoma is mature (benign), immature, or malignant.


• Diagnosis Timing: Pre-natal versus post-natal detection significantly impacts surgical planning.


• Complications: The presence of associated congenital anomalies or tumor-related pressure on pelvic organs.


• Surgical Completeness: Ensuring total resection of the coccyx is vital to prevent local recurrence of the Sacrococcygeal Teratoma.

How have outcomes for Sacrococcygeal Teratoma improved?

Over the last few decades, survival rates for infants born with Sacrococcygeal Teratoma have increased dramatically due to improvements in perinatal intensive care and surgical techniques. Modern surgical approaches focus not only on survival but also on minimizing long-term functional deficits, such as bowel or bladder dysfunction, which can occur if the pelvic floor nerves are affected during the removal of the Sacrococcygeal Teratoma.

What is the importance of long-term follow-up?

Because there is a risk of recurrence or late-onset malignancy, consistent medical monitoring is essential. Even after successful surgery, children with a history of Sacrococcygeal Teratoma require long-term surveillance. Regular screenings, often involving blood tests for tumor markers like alpha-fetoprotein (AFP) and periodic imaging, are standard practice to ensure long-term health and a high quality of life.

Next steps

• Consult with a pediatric surgeon or neonatologist specializing in fetal health.


• Join the DiseaseMaps.org community to connect with other families who have experience with Sacrococcygeal Teratoma.


• Maintain a detailed medical record of all surgical reports and follow-up imaging.


• Seek support from a pediatric psychologist if your child experiences anxiety regarding medical procedures.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional regarding any specific diagnosis or treatment plan.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sacrococcygeal Teratoma.


• Orphanet: Sacrococcygeal teratoma (ORPHA:3300).


• Children's Oncology Group (COG): Clinical guidelines for germ cell tumors.


• PubMed: Longitudinal studies on functional outcomes in survivors of Sacrococcygeal Teratoma.